Technical Analysis for PETQ - PetIQ, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| See historical PETQ trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Sep 21 | Narrow Range Bar | Range Contraction | 0.00% |
| Sep 21 | NR7 | Range Contraction | 0.00% |
| Sep 20 | 20 DMA Support | Bullish | 0.97% |
| Sep 20 | 180 Bullish Setup | Bullish Swing Setup | 0.97% |
| Sep 20 | Multiple of Ten Bullish | Other | 0.97% |
| Sep 20 | Inside Day | Range Contraction | 0.97% |
| Sep 19 | 20 DMA Support | Bullish | 4.16% |
| Sep 19 | Slingshot Bullish | Bullish Swing Setup | 4.16% |
| Sep 19 | Multiple of Ten Bearish | Other | 4.16% |
| Sep 18 | New 52 Week High | Strength | -0.38% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2018-11-05
- Sector: Non-Cyclical Consumer Goods & Services
- Industry: Pet Food Manufacturing
PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more PETQ news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 43.93 |
| 52 Week Low | 17.03 |
| Average Volume | 770,053 |
| 200-Day Moving Average | 25.3951 |
| 50-Day Moving Average | 33.5226 |
| 20-Day Moving Average | 39.8895 |
| 10-Day Moving Average | 41.097 |
| Average True Range | 2.2419 |
| ADX | 45.13 |
| +DI | 28.509 |
| -DI | 15.5742 |
| Chandelier Exit (Long, 3 ATRs ) | 37.2043 |
| Chandelier Exit (Short, 3 ATRs ) | 43.2657 |
| Upper Bollinger Band | 43.3042 |
| Lower Bollinger Band | 36.4748 |
| Percent B (%b) | 0.75 |
| BandWidth | 17.120796 |
| MACD Line | 2.2267 |
| MACD Signal Line | 2.5401 |
| MACD Histogram | -0.3134 |
| Fundamentals | Value |
|---|---|
| Market Cap | 550.21 Million |
| Num Shares | 13.2 Million |
| EPS | 0.50 |
| Price-to-Earnings (P/E) Ratio | 83.22 |
| Price-to-Sales | 0.00 |
| Price-to-Book | 0.00 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 43.01 | ||||
| Resistance 3 (R3) | 43.02 | 42.57 | 42.77 | ||
| Resistance 2 (R2) | 42.57 | 42.21 | 42.56 | 42.69 | |
| Resistance 1 (R1) | 42.09 | 42.00 | 42.33 | 42.08 | 42.62 |
| Pivot Point | 41.64 | 41.64 | 41.76 | 41.63 | 41.64 |
| Support 1 (S1) | 41.16 | 41.28 | 41.40 | 41.15 | 40.60 |
| Support 2 (S2) | 40.71 | 41.07 | 40.70 | 40.53 | |
| Support 3 (S3) | 40.23 | 40.71 | 40.45 | ||
| Support 4 (S4) | 40.22 |
